Loading market dashboard

Estimates, scoring, valuation assumptions, and peer comparison in one research surface.
Ambrx Biopharma Inc. · Forecast overview
Bars show expected revenue while the line tracks expected EPS.
| Period | Revenue avg | Revenue range | EBITDA | EPS avg | Analysts |
|---|---|---|---|---|---|
| Dec 2025 | $4.59M | $6.44M - $2.65M | -$4.38M | -$0.885 | 9 |
| Dec 2024 | $6.00M | $6.00M - $6.00M | -$5.73M | -$1.26 | 5 |
| Dec 2023 | $4.15M | $4.15M - $4.15M | -$3.96M | -$1.33 | 5 |
| Dec 2022 | $5.64M | $7.90M - $3.25M | -$5.38M | -$0.191 | 1 |
| Dec 2021 | $4.00M | $5.61M - $2.31M | -$3.82M | $0.07 | 2 |